Application Nr Approved Date Route Status External Links
ANDA212026 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Hypertension Propranolol Hydrochloride Extended-Release Capsules Are Indicated In The Management Of Hypertension. It May Be Used Alone Or Used In Combination With Other Antihypertensive Agents, Particularly A Thiazide Diuretic. Propranolol Hydrochloride Extended-Release Capsules Are Not Indicated In The Management Of Hypertensive Emergencies. Angina Pectoris Due To Coronary Atherosclerosis Propranolol Hydrochloride Extended-Release Capsules Are Indicated To Decrease Angina Frequency And Increase Exercise Tolerance In Patients With Angina Pectoris. Migraine Propranolol Hydrochloride Extended-Release Capsules Are Indicated For The Prophylaxis Of Common Migraine Headache. The Efficacy Of Propranolol In The Treatment Of A Migraine Attack That Has Started Has Not Been Established, And Propranolol Is Not Indicated For Such Use. Hypertrophic Subaortic Stenosis Propranolol Hydrochloride Extended-Release Capsules Improve Nyha Functional Class In Symptomatic Patients With Hypertrophic Subaortic Stenosis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Propranolol Hydrochloride PROPRANOLOL HYDROCHLORIDE ZINC20240

Comments